Filing Details

Accession Number:
0001315406-10-000061
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-11-18 18:50:44
Reporting Period:
2010-11-18
Filing Date:
2010-11-18
Accepted Time:
2010-11-18 18:50:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
12208 Bio Rad Laboratories Inc BIO, BIO.B Laboratory Analytical Instruments (3826) 941381833
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1278861 A Christine Tsingos C/O Bio-Rad Laboratories, Inc.
1000 Alfred Nobel Drive
Hercules CA 94547
Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Bio-Rad A Common Stock Acquisiton 2010-11-18 5,000 $57.49 8,335 No 4 M Direct
Bio-Rad A Common Stock Acquisiton 2010-11-18 4,000 $62.47 12,335 No 4 M Direct
Bio-Rad A Common Stock Disposition 2010-11-18 9,000 $95.03 3,335 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Bio-Rad A Common Stock Incentive Stock Option (right to buy) Disposition 2010-11-18 1,617 $0.00 1,617 $57.49
Bio-Rad A Common Stock Non-Qualified Stock Option (right to buy) Disposition 2010-11-18 3,383 $0.00 3,383 $57.49
Bio-Rad A Common Stock Incentive Stock Option (right to buy) Disposition 2010-11-18 680 $0.00 680 $62.47
Bio-Rad A Common Stock Non-Qualified Stock Option (right to buy) Disposition 2010-11-18 3,320 $0.00 3,320 $62.47
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2015-02-09 No 4 M Direct
0 2015-02-09 No 4 M Direct
1,000 2016-04-03 No 4 M Direct
0 2016-04-03 No 4 M Direct
Footnotes
  1. Includes 99.0544 shares acquired under the Bio-Rad Laboratories employee stock purchase plan on September 30, 2010.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.96 to $95.13. The reporting person undertakes to provide to Bio-Rad Laboratories, any security holder of Bio-Rad Laboratiores, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The stock option, granted on February 9, 2005, vested over five years at 20% per year on the yearly anniversary date of the grant.
  4. The stock option, granted on April 3, 2006, vests over five years at 20% per year on the yearly anniversary date of the grant.